Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: An experimental In Vivo study

Luigi Dall'Olmo, Matteo Fassan, Elisa Dassie, Marco Scarpa, Stefano Realdon, Francesco Cavallin, Matteo Cagol, Giorgio Battaglia, Marco Pizzi, Vincenza Guzzardo, Erica Franceschinis, Gianfranco Pasut, Massimo Rugge, Giovanni Zaninotto, Nicola Realdon, Carlo Castoro

Research output: Contribution to journalArticlepeer-review

Abstract

Chronic gastro-duodenal reflux in the esophagus is a major risk for intestinal metaplasia and Barrett's adenocarcinoma. A role for chronic use of proton pump inhibitor (PPI) in the increased incidence of esophageal adenocarcinoma in Western countries has been previously suggested. The aim of this work was to study the effect of chronic administration of omeprazole (a proton pump inhibitor) per os in a model of reflux induced esophageal carcinogenesis. One week after esophago-gastro-jejunostomy, 115 Sprague-Dawley rats were randomized to receive 10 mg/Kg per day of omeprazole or placebo, 5 days per week. The esophago-gastric specimens were collected 28±2 weeks after randomization and analyzed in a blinded fashion. Mortality and esophageal metaplasia rates did not differ between the two groups (p = 0.99 for mortality, p = 0.36 for intestinal metaplasia and p = 0.66 for multi-layered epithelium). Gastric pancreatic acinar cell metaplasia (PACM) was more frequently observed in PPI-treated rats (p = 0.003). Severe ulcer lesions significantly prevailed in the placebo group (p = 0.03). Locally invasive esophageal epithelial neoplasia were observed in 23/39 PPI-treated versus 14/42 placeboanimals (p = 0.03). In conclusion, chronic omeprazole treatment improved the healing of esophageal ulcerative lesions. Locally invasive neoplastic lesions and PACM prevailed among PPI-treated animals. However, neither an effect on the overall mortality nor on the incidence of pre-neoplastic lesions was observed in this work.

Original languageEnglish
Article number0112862
JournalPLoS One
Volume9
Issue number11
DOIs
Publication statusPublished - Nov 21 2014

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Fingerprint

Dive into the research topics of 'Role of proton pump inhibitor on esophageal carcinogenesis and pancreatic acinar cell metaplasia development: An experimental In Vivo study'. Together they form a unique fingerprint.

Cite this